10x Genomics (TXG) Other Accumulated Expenses (2018 - 2026)

10x Genomics' Other Accumulated Expenses history runs 9 years deep, the most recent figure standing at $8.4 million for Q1 2026.

• In Q1 2026, Other Accumulated Expenses fell 31.42% year-over-year to $8.4 million; the TTM figure through Mar 2026 stood at $8.4 million (down 31.42% YoY), while the FY2025 annual figure was $11.0 million, changed N/A from the prior year.
• Other Accumulated Expenses came in at $8.4 million for Q1 2026 at 10x Genomics, down from $11.0 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $12.8 million in Q2 2025 to a low of $3.3 million in Q2 2023.
• A 5-year average of $7.3 million and a median of $6.0 million in 2022 frame the typical range for Other Accumulated Expenses.
• On a YoY basis, Other Accumulated Expenses climbed as much as 657.19% in 2022 and fell as far as 83.31% in 2022.
• 10x Genomics' Other Accumulated Expenses stood at $6.7 million in 2022, then plunged by 34.2% to $4.4 million in 2023, then rose by 29.59% to $5.7 million in 2024, then surged by 92.25% to $11.0 million in 2025, then retreated by 23.28% to $8.4 million in 2026.
• According to Business Quant data, Other Accumulated Expenses over the past three periods registered $8.4 million, $11.0 million, and $12.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison